Vidofludimus calcium lowers NfL levels in progressive MS

[BettysMom]

This is an ongoing research study into a drug which may potentially be very useful in all forms of MS.

Treatment with Immunic Therapeutics‘ experimental oral therapy vidofludimus calcium (IMU-838) lowered the levels of a nerve damage marker in people with all subtypes of progressive multiple sclerosis (MS), including those without recent inflammatory activity.

multiplesclerosisnewstoday....

[Greentime]

This could be fantastic news. Exciting to think about.

[CatsandCars]

I hope this makes it to market. The neuroprotective aspect sounds promising, as does the possibility of it helping with fatigue.